BIONTECH
OpenCalais Metadata: Ticker
OpenCalais Metadata: LegalName
Efficacy of Pfizer/BioNTech Coronavirus Vaccine Drops to 84pc after 6 Months
The efficacy of the Pfizer/BioNTech coronavirus vaccine fell from 96% to 84% after six months, a new preprint report by medRxiv showed on Wednesday.
Covid-19 Quarantine in Sydney Has Been Extended with 1 Month
A Sydney home order was issued five weeks ago as authorities tried to curb the spread of the new coronavirus, the Indian or delta variant.
The quarantine was scheduled to be lifted on July 30, but will remain in effect until August 28, as the number of Covid-19 cases continues to rise.
Moderna COVID-19 vaccine to become available to people aged 12-17 on August 2
Head of the National COVID-19 Vaccination Coordination Committee (CNCAV) Valeriu Gheorghita said on Tuesday that from August 2, in Romania, 12 to 17-year-olds will be able to be immunised against COVID-19 with the vaccine produced by Moderna, with appointments being available in the vaccination platform starting on August 1.
Melbourne to lift virus lockdown as Delta outbreak contained
Melbourne's coronavirus lockdown will be lifted late on July 27, as authorities signalled a Delta variant outbreak in Australia's second-biggest city had been contained.
Neighbouring South Australia state will also ease stay-at-home rules, but the country's largest city Sydney was facing a likely extension to a lockdown now in its fifth week.
Η Βρετανία θα εμβολιάσει τους κλινικά ευάλωτους 12-15 ετών
Το εμβόλιο που θα χρησιμοποιηθεί θα είναι των Pfizer/BioNTech
New tranche of Pfizer BioNtech vaccine to arrive at Otopeni airport
A new tranche of the Pfizer BioNTech vaccine, 662,220 doses, will arrive at the Otopeni airport on Monday, the National Coordinating Committee for Vaccination Activities against COVID-19 informs in a press release sent to AGERPRES. The transportation of the vaccine doses to the storage centre is provided by the manufacturing company, including by land.
Study Compares Pfizer-BioNTech and Sinovac Vaccines
People who receive a COVID vaccine from Pfizer-BioNTech produce 10 times more antibodies than those who opted for Sinovac's CoronaVac, a Chinese drug. This was reported on Friday, July 16 by South China Morning Post with reference to relevant research.
Reinstating restrictions not necessary, says health minister
Despite the success of the ongoing vaccination program, COVID-19 cases are on the rise, but presently there is no need to impose restrictions, Health Minister Fahrettin Koca has said.
Data from the Health Ministry show that the daily virus cases inched up above 6,000 cases over the last couple of days after plateauing to around 5,000 in the past weeks.
Covid certificate mandatory for entering Slovenia as of 15 July
Ljubljana – Slovenia will tighten rules on the border starting on 15 July, as the colour-coded lists of countries will be cast aside in favour of the requirement that passengers who wish to enter the country will need to have a Covid certificate showing they have been vaccinated, tested or have recovered from coronavirus, regardless of where they come from.
Buy this article for 1€
CoronaVac vaccine 83.5 percent effective: Turkish study
Interim results from a phase 3 trial in Turkey have shown that two doses of CoronaVac, a vaccine developed by the Chinese firm Sinovac, are 83.5 percent effective against symptomatic COVID-19.